Royalty Pharma RPRX
NASDAQ RPRX
$56.93 +0.72 (+1.28%)
At close: Oct 9, 2026 · 4:00 PM EDT

Royalty Pharma (RPRX) Net of Acquisitions & Divestments (2025)

Updated

Analysis

Royalty Pharma (RPRX) Net of Acquisitions & Divestments (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Rocket Companies 43.07 Bn 28.75 Bn - -
2 Orix 41.51 Bn 42.01 Bn 4.68 Bn -
3 Royalty Pharma 32.73 Bn 32.65 Bn - -
4 Affirm Holdings 27.21 Bn 20.90 Bn - -
5 Synchrony Financial 23.66 Bn -44.31 Bn - -
6 Federal National Mortgage Association Fannie Mae 23.53 Bn 23.53 Bn - -
7 Royal Gold 20.00 Bn 19.23 Bn 390.45 Mn -
8 Annaly Capital Management 13.74 Bn 4.84 Bn - -
9 Ares Capital 13.33 Bn 10.76 Bn - -
10 Federal Home Loan Mortgage 11.90 Bn -6.84 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -226,000.00
API Access

Royalty Pharma Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=RPRX&period=max&api_key=YOUR_API_KEY